Tender Offer of Jeisys Medical by Archimed Group

• On 10 June, it was announced that France's Archimed Group is conducting a tender offer of 55.72 million shares of Jeisys Medical (287410 KS) (72% of outstanding shares).

• The tender offer period will run from 10 June to 22 July. The tender offer price is 13,000 won.

• Archimed also signed a contract to purchase the entire stake (23.2%) held by Kang Don-Hwan (Chairman of Jeisys Medical) and (3.2%) held by a Director Myung-Hoon Lee.

On 10 June, it was announced that France's Archimed Group (a French investment company) is conducting a tender offer of 55.72 million shares of Jeisys Medical (287410 KS) (72% of outstanding shares) through its affiliate Syracuse SubCo Inc. The tender offer period will run from 10 June to 22 July.

The tender offer amount is 724.4 billion won (13,000 won x 55.72 million shares). If the tender offer is successful, Archimed will own 76.18 million common shares (98.44% of the total number of potentially issued shares). If Archimed is successful in this tender offer, it is expected that Jeisys Medical will be eventually delisted.

Archimed Group is a French investment company specializing in the healthcare sector. The tender offer price is 13,000 won, which is 20.8% higher than the closing price on 9 June. Shares of Jeisys Medical is up 18.6% to 12,760 won. A 24.15 million shares traded today. Archimed plans to purchase all of the shares submitted in this tender offer if it exceeds 18.01 million shares (28.3% stake) and it will withdraw the tender offer if it is less than this amount. We believe that Archimed is likely to successfully complete this tender offer and eventually take Jeisys Medical private.